Clinical Trial Update: The Effect of Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating somatostatin as a treatment for posthepatectomy liver failure, with current status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Drugs mentioned

• Somatostatin (somatostatin)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Liver Failure | Phase 3 | Status: UNKNOWN